Unique research results from study with Multi Frequency Vibrometry to be presented at the European Association for the Study of Diabetes

Chief physician Dr. Eero Lindholm at Skånes University Hospital will present unique research at the European Association for the Study of Diabetes Annual Meeting (EASD) in Munich in September 2016. One conclusion from the study is that Multi Frequency Vibrometry discloses a strong correlation between high Vibration Perception Thresholds and diabetic foot ulcers. Doctor Lindholm is selected by EASD for an oral presentation of his abstract and his findings

Dr. Lindholm has extracted data from studies conducted with Multi Frequency Vibrometry. The data demonstrate that the method disclose a strong correlation between sensory loss on the sole of the foot and foot ulcers in diabetic patients, due to diabetic neuropathy.

Moreover, Dr. Lindholm show that reduced sensitivity at low frequencies correlate to an increased risk for foot ulcers which can indicate impairment of sensory cells, Merkel cells and Meissner's corpuscles as a consequence of diabetes.

- It's very interesting results which will be presented to diabetes scientists and physicians from around the world. We have found that there is a strong correlation between foot ulcers and impaired tactile sensation at low vibration frequencies. It will be very interesting to analyze all of the data to be obtained during the three years of the study, says Eero Lindholm, chief physician at Skånes University Hospital, Sweden.

Contact information

Toni Speidel, CEO, VibroSense Dynamics AB, +46 40 650 14 12, info@vibrosense.com , www.vibrosense.com

About VibroSense Dynamics AB (public)

VibroSense Dynamics AB (public) develops and markets efficient systems for early detection and diagnosis of peripheral sensory neuropathy, i.e. disease of large nerve fibers and nerve trunks in the legs and arms.

The Company, founded in 2005, is listed on the Small Cap list AktieTorget since May 2015. The product portfolio includes a CE-marked medical device, the VibroSense Meter, for diagnostics of impaired sensitivity in the hands.

About Us

VibroSense Dynamics AB (public) develops and markets efficient systems for early detection and diagnosis of peripheral sensory neuropathy, i.e. disease of large nerve fibers and nerve trunks in the legs and arms. The Company, founded in 2005, is listed on the Small Cap list AktieTorget since May 2015. The product portfolio includes a CE-marked medical device, the VibroSense Meter, for diagnostics of impaired sensitivity in the hands. www.vibrosense.com

Subscribe

Documents & Links